Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 1/20 | 0.39 |
| ▸ | CMA1 | P23946 | 3/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.34 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.33 |
| ▸ | GUCY1B2 | O75343 | 2/20 | 0.33 |
| ▸ | GUCY1A2 | P33402 | 2/20 | 0.33 |
| ▸ | GUCY1A1 | Q02108 | 2/20 | 0.33 |
| ▸ | GUCY1B1 | Q02153 | 2/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1549920 | 0.75 | IDO1 (0.40) | CMA1SCN5ASSTR4ALDH1A1LMNA | |
| SCHEMBL27481676 | 0.73 | ALDH1A1 (0.42) | P2RX7CMA1ALDH1A1LMNATAAR1 | |
| SCHEMBL5221235 | 0.72 | KDM4E (0.49) | ALDH1A1LMNA | |
| SCHEMBL1549969 | 0.71 | ALDH1A1 (0.46) | P2RX7CMA1SCN9AALDH1A1LMNA | |
| SCHEMBL12900215 | 0.68 | GABRA1 (0.46) | P2RX7CMA1PTGS2KCNH2SCN5A | |
| SCHEMBL1508426 | 0.66 | FFAR1 (0.43) | P2RX7PTGS2ALDH1A1 | |
| SCHEMBL3511351 | 0.66 | KDM4E (0.46) | ALDH1A1LMNAL3MBTL1 | |
| SCHEMBL20324277 | 0.65 | LMNA (0.40) | SSTR4ALDH1A1LMNA | |
| SCHEMBL16701725 | 0.65 | SLC6A4 (0.39) | P2RX7CMA1PTGS2KCNH2LMNA | |
| SCHEMBL488739 | 0.65 | PDK2 (0.41) | P2RX7CMA1PTGS2KCNH2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110144374-A1 | OXIME ETHER DERIVATIVE AND FUNGICIDE FOR AGRICULTURE AND HORTICULTURE | NIPPON SODA CO., LTD. (JP) | 2011-06-16 | — | — | US | disclosed |
| EP-2314570-A1 | OXIME ETHER DERIVATIVE AND BACTERICIDE FOR AGRICULTURAL AND HORTICULTURAL USE | Nippon Soda Co., Ltd. (JP) | 2011-04-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110144374-A1 | OXIME ETHER DERIVATIVE AND FUNGICIDE FOR AGRICULTURE AND HORTICULTURE | CBR3, CNPY2, NOX3 | P2RX7 4213/4885CMA1 2556/4885PTGS2 2866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.